Pfizer acquired Biohaven Pharmaceuticals, Seagen, and Arena Pharmaceuticals in transactions dating back to 2022.
2 reports, 1 independent
Updated Aug 18
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Pfizer acquired Biohaven Pharmaceuticals, Seagen, and Arena Pharmaceuticals in transactions dating back to 2022.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Financial analysts reviewed Biohaven's strategic asset sales and corporate strategy following its acquisition by Pfizer.Sub-event
Pfizer completed multiple acquisitions, including Biohaven, Seagen, and Arena.1 source
Keep exploring
The entities involved
-
Pfizer
American multinational pharmaceutical and biotechnology corporation
-
Seagen
American biotechnology company
Nothing else this week.
-
Arena Pharmaceuticals
American biopharmaceutical company
Nothing else this week.
Related events
- A group of major pharmaceutical companies, including AbbVie, Bristol-Myers Squibb, Amgen, Pfizer, Moderna, and Merck, are noted as peers operating in the highly regulated pharmaceutical sector.
- Pfizer and Nexentis Technologies, both healthcare companies, are competing for investment, with Pfizer reporting higher revenue and earnings.
- Major pharmaceutical companies are competing for investment capital.
- BioNTech announced new partnerships with Genmab, Pfizer, Bristol-Myers Squibb, and Genentech.